Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples